Determining and Achieving Therapeutic Targets in Attention-Deficit/Hyperactivity Disorder.

Joseph Biederman, M.D., opened the symposium by reviewing the history of attention-deficit/hyperactivity disorder (ADHD), neurologic impairment in individuals with ADHD, and the prevalence of the disorder and comorbid conditions. Dr. Biederman also explained how, together, symptoms and comorbid conditions result in the impairments associated with ADHD.